Spire Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $671K | Sell |
9,721
-3,141
| -24% | -$217K | 0.02% | 449 |
|
|
2025
Q1 | $893K | Buy |
12,862
+978
| +8% | +$67.9K | 0.03% | 427 |
|
|
2024
Q4 | $1.02M | Sell |
11,884
-7,190
| -38% | -$618K | 0.03% | 391 |
|
|
2024
Q3 | $2.27M | Buy |
19,074
+2,797
| +17% | +$333K | 0.08% | 207 |
|
|
2024
Q2 | $2.32M | Buy |
16,277
+1,878
| +13% | +$268K | 0.08% | 215 |
|
|
2024
Q1 | $1.85M | Buy |
14,399
+5,083
| +55% | +$653K | 0.03% | 262 |
|
|
2023
Q4 | $996K | Buy |
9,316
+3,209
| +53% | +$343K | 0.03% | 360 |
|
|
2023
Q3 | $555K | Buy |
6,107
+13
| +0.2% | +$1.18K | 0.02% | 456 |
|
|
2023
Q2 | $493K | Sell |
6,094
-478
| -7% | -$38.7K | 0.02% | 490 |
|
|
2023
Q1 | $523K | Buy |
6,572
+2,844
| +76% | +$226K | 0.02% | 479 |
|
|
2022
Q4 | $252K | Buy |
3,728
+306
| +9% | +$20.7K | 0.01% | 496 |
|
|
2022
Q3 | $170K | Sell |
3,422
-3,766
| -52% | -$187K | 0.01% | 574 |
|
|
2022
Q2 | $400K | Sell |
7,188
-4,150
| -37% | -$231K | 0.02% | 540 |
|
|
2022
Q1 | $630K | Sell |
11,338
-3,434
| -23% | -$191K | 0.02% | 509 |
|
|
2021
Q4 | $827K | Buy |
14,772
+818
| +6% | +$45.8K | 0.02% | 529 |
|
|
2021
Q3 | $670K | Sell |
13,954
-1,744
| -11% | -$83.7K | 0.02% | 512 |
|
|
2021
Q2 | $658K | Sell |
15,698
-13,974
| -47% | -$586K | 0.02% | 537 |
|
|
2021
Q1 | $1M | Buy |
+29,672
| New | +$1M | 0.03% | 438 |
|